pravastatin has been researched along with Coronary Occlusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lingsma, HF; Mooijaart, SP; Nieboer, D; Steyerberg, EW; Trompet, S; van Leeuwen, N | 1 |
| Farmer, JA; Jones, PH | 1 |
1 review(s) available for pravastatin and Coronary Occlusion
| Article | Year |
|---|---|
Adjunctive interventions in myocardial infarction: the role of statin therapy.
Topics: Acute Coronary Syndrome; Anticholesteremic Agents; Atorvastatin; Coronary Artery Disease; Coronary Circulation; Coronary Occlusion; Dyslipidemias; Endothelium, Vascular; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic | 2008 |
1 other study(ies) available for pravastatin and Coronary Occlusion
| Article | Year |
|---|---|
Regression discontinuity was a valid design for dichotomous outcomes in three randomized trials.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anticholesteremic Agents; Causality; Confidence Intervals; Coronary Occlusion; Craniocerebral Trauma; Fibrinolytic Agents; Humans; Logistic Models; Middle Aged; Odds Ratio; Pravastatin; Randomized Controlled Trials as Topic; Regression Analysis; Reproducibility of Results; Streptokinase; Tissue Plasminogen Activator; Treatment Outcome; Vascular Diseases; Young Adult | 2018 |